CuraTeQ Biologics reports Phase 3 results for BP11 biosimilar to Xolair
Study meets primary endpoints in chronic spontaneous urticaria across Europe and India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Bayer revises access model for Eylea 2mg in India to expand patient eligibility
Company aims to lower upfront cost to support early treatment initiation for retinal diseases
Leading people in the age of AI
As AI reshapes pharma, HR leadership is being drawn into a deeper question that goes beyond technology to the future of people and…
Patent expiries ahead, is India Pharma Inc ready?
Beyond the semaglutide momentum, a larger wave of patent expiries is set to unfold between 2026 and 2032. For Indian pharma, the…
Emcure Pharmaceuticals revises price of Poviztra semaglutide injection in India
Weight management drug to be available from Rs 3,999 per month from April 3, 2026
Mumbai Experience Center reflects Agilent’s continued commitment to India
Bharat Bhardwaj, Vice President, Asia Pacific, Agilent Technologies spoke to Viveka Roychowdhury on why Agilent has been…
Lupin completes acquisition of VISUfarma
The integration of VISUfarma has expanded Lupin’s ophthalmology portfolio to over 60 branded products spanning dry eye, glaucoma,…
Glenmark to manage end-to-end commercialisation and distribution for RYALTRIS in US
RYALTRIS is Glenmark’s first innovative product introduced into the US market
Agilent expands India’s scientific ecosystem with new customer experience centre in Mumbai
Agilent Technologies has announced the opening of its Customer Experience Center (CEC) and office in Mumbai, reinforcing its…
Midst global headwinds, CDSCO cracks down on GLP-1 gold rush
As pharma companies deal with price wars, increasing regulatory heat and a volatile geopolitical situation, navigating this…
Enthral.ai partners with Alembic Pharmaceuticals to deploy LMS platform
Platform to support compliance, training and documentation for over 9,000 learners
Eli Lilly to acquire Centessa Pharmaceuticals under definitive agreement
Acquisition to include orexin receptor portfolio for sleep and neurological conditions
Granules Life Sciences receives VAI classification following US FDA inspection
Granules India announced that its wholly owned subsidiary, Granules Life Sciences (GLS), has concluded a recent US FDA inspection…
Rusan unveils APOSAN 3ml multi-dose pen for treatment of motor fluctuations
Rusan Healthcare, the marketing and distribution arm of Rusan Pharma, an integrated global pharmaceutical company, has announced…
CORONA Remedies announces strategic acquisition of Wokadine in India
CORONA Remedies announced the acquisition of Wokadine from Dr. Reddy’s Laboratories, a global pharmaceutical company headquartered…
HRV Pharma, Shodhana partner to accelerate next-gen API development
HRV Pharma, India's first integrated Virtual API and Pharmtech company announced a comprehensive, multi-year Contract Development…
Shreehas Tambe appointed CEO & MD of Biocon, effective April 1, 2026
Biocon announced the appointment of Shreehas Tambe as its Chief Executive Officer & Managing Director, effective April 1,…
India’s opportunity to lead next generation injectable drug innovation
India is rapidly evolving into a global hub for generic injectable drugs, driven by rising disease burden, cost efficient…
Kinny Singh appointed Deputy Secretary in Department of Pharmaceuticals
IAS officer Kinny Singh has been appointed as Deputy Secretary in the Department of Pharmaceuticals under the Central Staffing…
Lupin receives tentative approval from US FDA for Pitolisant tablets
Global pharma major Lupin announced that it has received tentative approval from the United States Food and Drug Administration…